Accesso libero

Diffusion kurtosis imaging and conventional diffusion weighted imaging to assess electrochemotherapy response in locally advanced pancreatic cancer

Vincenza Granata

Vincenza Granata

Division of Radiology, Instituto Nazionale Tumori – IRCCS – Fondazione G. PascaleNapoli, Italia
Cerca questo autore su
Sciendo|Google Scholar
Granata, Vincenza
, 
Roberta Fusco

Roberta Fusco

IGEA SpANapoli, Italia
Cerca questo autore su
Sciendo|Google Scholar
Fusco, Roberta
, 
Sergio Venanzio Setola

Sergio Venanzio Setola

Division of Radiology, Instituto Nazionale Tumori – IRCCS – Fondazione G. PascaleNapoli, Italia
Cerca questo autore su
Sciendo|Google Scholar
Setola, Sergio Venanzio
, 
Raffaele Palaia

Raffaele Palaia

Division of Hepatobiliary Surgical Oncology, Unit, Instituto Nazionale Tumori, IRCCS, Fondazione G. PascaleNapoli, Italia
Cerca questo autore su
Sciendo|Google Scholar
Palaia, Raffaele
, 
Vittorio Albino

Vittorio Albino

Division of Hepatobiliary Surgical Oncology, Unit, Instituto Nazionale Tumori, IRCCS, Fondazione G. PascaleNapoli, Italia
Cerca questo autore su
Sciendo|Google Scholar
Albino, Vittorio
, 
Mauro Piccirillo

Mauro Piccirillo

Division of Hepatobiliary Surgical Oncology, Unit, Instituto Nazionale Tumori, IRCCS, Fondazione G. PascaleNapoli, Italia
Cerca questo autore su
Sciendo|Google Scholar
Piccirillo, Mauro
, 
Robert Grimm

Robert Grimm

Siemens Healthcare GmbHErlangen, Germany
Cerca questo autore su
Sciendo|Google Scholar
Grimm, Robert
, 
Antonella Petrillo

Antonella Petrillo

Division of Radiology, Instituto Nazionale Tumori – IRCCS – Fondazione G. PascaleNapoli, Italia
Cerca questo autore su
Sciendo|Google Scholar
Petrillo, Antonella
 e 
Francesco Izzo

Francesco Izzo

Division of Hepatobiliary Surgical Oncology, Unit, Instituto Nazionale Tumori, IRCCS, Fondazione G. PascaleNapoli, Italia
Cerca questo autore su
Sciendo|Google Scholar
Izzo, Francesco
  
19 gen 2019
Diffusion kurtosis imaging and conventional diffusion weighted imaging to assess electrochemotherapy response in locally advanced pancreatic cancer's Cover Image
INFORMAZIONI SU QUESTO ARTICOLO
Articolo precedente
Articolo Successivo
Cita
Scarica la copertina
Categoria dell'articolo: Research Article
Pubblicato online: 19 gen 2019
Pagine: 15 - 24
Ricevuto: 24 set 2018
Accettato: 18 nov 2018
DOI: https://doi.org/10.2478/raon-2019-0004
Parole chiave
© 2019 Vincenza Granata, Roberta Fusco, Sergio Venanzio Setola, Raffaele Palaia, Vittorio Albino, Mauro Piccirillo, Robert Grimm, Antonella Petrillo, Francesco Izzo published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Figure 1

Boxplot of apparent diffusion coefficient (ADC) and diffusion kurtosis imaging (DKI) parameters pre and post treatment values between responders and not responders. MD = mean of diffusion coefficient; MK = mean of diffusional kurtosis
Boxplot of apparent diffusion coefficient (ADC) and diffusion kurtosis imaging (DKI) parameters pre and post treatment values between responders and not responders. MD = mean of diffusion coefficient; MK = mean of diffusional kurtosis

Figure 2

Boxplot of apparent diffusion coefficient (ADC) and diffusion kurtosis imaging (DKI) parameters percentage change values between responders and not responders. Delta (Δ) = percentage change between pre and post treatment; MD = mean of diffusion coefficient; MK = mean of diffusional kurtosis
Boxplot of apparent diffusion coefficient (ADC) and diffusion kurtosis imaging (DKI) parameters percentage change values between responders and not responders. Delta (Δ) = percentage change between pre and post treatment; MD = mean of diffusion coefficient; MK = mean of diffusional kurtosis

Figure 3

ROC curve of apparent diffusion coefficient (ADC) and diffusion kurtosis imaging (DKI) features to assess electrochemotherapy (ECT) response. MD = mean of diffusion coefficient; MK = mean of diffusional kurtosis
ROC curve of apparent diffusion coefficient (ADC) and diffusion kurtosis imaging (DKI) features to assess electrochemotherapy (ECT) response. MD = mean of diffusion coefficient; MK = mean of diffusional kurtosis

Figure 4

Adenocarcinoma of the pancreatic head. Before treatment in (A) (half-Fourier acquisition single-shot turbo spin-echo [HASTE] T2- Weighted [W] sequence), the lesion (arrow) appears hyperintense, in (B) (in-phase T1-W sequence) and (C) (out-phase T1-W sequence) appears hypointense and hypovascular in (D) (volumetric interpolated breath hold examination [VIBE] T1-W in equilibrium phase). After the treatment the lesion in (E) (HASTE T2-W sequence), (F) (in-phase T1-W sequence), (G) (out-phase T1-W sequence) and (H) (VIBE T1-W in equilibrium phase): there were not significant differences in size and signal compared to baseline. Apparent diffusion coefficient (ADC) map before and after treatment (I, J).
Adenocarcinoma of the pancreatic head. Before treatment in (A) (half-Fourier acquisition single-shot turbo spin-echo [HASTE] T2- Weighted [W] sequence), the lesion (arrow) appears hyperintense, in (B) (in-phase T1-W sequence) and (C) (out-phase T1-W sequence) appears hypointense and hypovascular in (D) (volumetric interpolated breath hold examination [VIBE] T1-W in equilibrium phase). After the treatment the lesion in (E) (HASTE T2-W sequence), (F) (in-phase T1-W sequence), (G) (out-phase T1-W sequence) and (H) (VIBE T1-W in equilibrium phase): there were not significant differences in size and signal compared to baseline. Apparent diffusion coefficient (ADC) map before and after treatment (I, J).

MRI protocol parameters

Sequence Orientation TR/TE/FA (ms/ms/deg.) FOV (mm2) Acquisition matrix Slice thickness/ gap (mm)
HASTE T2-W Axial 1500/90/180 380 × 380 320 × 320 5/0
FLASH T1-W, In-out phase Axial 160/4.87/70 285 × 380 192 × 256 5/0
FLASH T1-W, out phase Axial 178/2.3/80 325 × 400 416 × 412 3/0
DWI Axial 7500/91/90 340 × 340 192 × 192 3/0
VIBE T1-W Axial 4.89/2.38/10 325 × 400 320 × 260 3/0
TWIST T1-W, Pre and post contrast agent injection Axial 3.01/1.09/25 300 × 300 256 × 256 2/0

Electrochemotherapy (ECT) response classification for each patient

No. CT response according Choi DCE-MRI response according ΔWIS and ΔWOS PET response according PERCIST Consenssus among two modalities
1 PR PR PD PR
2 PR PR PR
3 PR PR PR PR
4 PR PR PR
10 PR CR PR
11 PR SD PR SD
12 SD PR SD SD
13 PR SD PR PR
14 PR PR PR PR
17 PR PR SD PR
18 PR PR SD PR
19 PR PR/SD PR PR
20 PR PR PR
21 SD SD SD

Diagnostic accuracy of MRI extracted parameters in discrimination of responders and not responders_

AUC 95% CI p value Sensitivity Specificity Cut-off
ΔADC 0,767 0,429–1,00 0,176 0,900 0,667 -25,775
ΔMK 0,533 0,229–0,837 0,866 0,500 1,000 14,555
ΔMD 0,933 0,782–1,000 0,028 0,800 1,000 -32,570
ADC PRE 0,667 0,292–1,000 0,398 0,700 0,667 1182,550
MK PRE 0,667 0,380–1,953 0,398 0,600 1,000 1348,700
MD PRE 0,700 0,360–1,000 0,310 0,400 1,000 2477,500
ADC POST 0,367 0,000–0,766 0,499 0,800 0,333 1177,825
MK POST 0,800 0,505–1,000 0,128 0,500 1,000 1299,075
MD POST 0,267 0,000–0,602 0,237 0,600 0,333 2020,725

Patients’ characteristics

Patients (n = 21)
Histotype, %
Adenocarcinoma 100 (21/21)
Location, %
Head 52.4 (11/21)
Body/tail 47.6 (10/21)
Largest diameter lesion, cm (range) 5.2 (2.2–9.9)
Venus involvement (superior mesenteric vein [SMV] or portal vein [PV]), %
Yes 81.0 (17/21)
No 19.0 (4/21)
Arterial encasement, %
Yes 57.1 (12/21)
No 42.9 (9/21)
Lingua:
Inglese
Frequenza di pubblicazione:
4 volte all'anno
Argomenti della rivista:
Medicina, Medicina clinica, Medicina interna, Ematologia, Oncologia, Radiologia
Feed RSS della rivista